---
title: "Sinocare released its performance for the first three quarters, with a net profit attributable to the parent company of 211 million yuan, a decrease of 17.36%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/262443500.md"
description: "According to the Zhitong Finance APP, Sinocare released its third-quarter report for 2025. The company's operating revenue for the first three quarters was 3.453 billion yuan, a year-on-year increase of 8.52%. The net profit attributable to shareholders of the listed company was 211 million yuan, a year-on-year decrease of 17.36%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 180 million yuan, a year-on-year decrease of 22.13%. The basic earnings per share were 0.3827 yuan"
datetime: "2025-10-23T12:51:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/262443500.md)
  - [en](https://longbridge.com/en/news/262443500.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/262443500.md)
---

# Sinocare released its performance for the first three quarters, with a net profit attributable to the parent company of 211 million yuan, a decrease of 17.36%

According to the Zhitong Finance APP, Sinocare (300298.SZ) released its third-quarter report for 2025. The company's operating revenue for the first three quarters was 3.453 billion yuan, an increase of 8.52% year-on-year. The net profit attributable to shareholders of the listed company was 211 million yuan, a decrease of 17.36% year-on-year. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 180 million yuan, a decrease of 22.13% year-on-year. The basic earnings per share were 0.3827 yuan

### Related Stocks

- [300298.CN](https://longbridge.com/en/quote/300298.CN.md)

## Related News & Research

- [Phase 3-ready cancer biotech Parabilis Medicines files for a $100 million IPO](https://longbridge.com/en/news/286972125.md)
- [New York Governor Signs Bills To Preserve Mandatory Vaccines](https://longbridge.com/en/news/286947583.md)
- [Microbiotica reports positive results for MB097 in advanced melanoma](https://longbridge.com/en/news/286740265.md)
- [09:35 ETOpen Medicine Launches Ahead of ASCO, Introducing "Living Algorithms" for Real-Time Oncology Decision-Making](https://longbridge.com/en/news/286923155.md)
- [08:59 ETPurina Institute Drives the Conversation on Microbiome Innovation in Veterinary Medicine](https://longbridge.com/en/news/286917434.md)